Breaking Alzheimer's Disease Barrier: The Role of Xanthoceras sorbifolia Bunge Oil in Gut‐Brain Axis and TLR4 /Myd88/ MAPK Pathway Inhibition
Phytotherapy Research · 2026-11 · 40 (11) · 6216-6232
DOI: 10.1002/ptr.70432 ↗At a glance
Journal article in Phytotherapy Research, published online on 2026-08-24. Written by Lijing Du and 8 co-authors. Institution: Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China. Major MEDLINE topics: Alzheimer Disease, Plant Oils, Sapindaceae. 56 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Natural Science Foundation of China, National Key R&D Program of China, Joint Funds of National Natural Science Foundation of China.
Topics: Demenz
Abstract (original language)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with cognitive decline and neuroinflammation. Xanthoceras sorbifolia Bunge oil (XSBO), a woody plant oil rich in bioactive fatty acids, has shown potential health benefits. This study aimed to investigate the neuroprotective effects and underlying mechanisms of XSBO in AD. A scopolamine‐induced AD rat model was established to evaluate the effects of XSBO on cognitive function, pathological changes, and neuroinflammation. Gut microbiota alterations were analyzed by 16S rDNA sequencing. Fecal microbiota transplantation (FMT) and short‐chain fatty acid (SCFA) supplementation experiments were performed to explore the role of gut microbiota‐derived metabolites. The TLR4/MyD88/MAPK signaling pathway was further examined. XSBO treatment improved cognitive deficits, reduced neuronal damage and neuroinflammation, and enhanced intestinal barrier integrity in AD rats. XSBO restored gut microbiota dysbiosis and increased SCFA‐producing bacteria. FMT and SCFA supplementation confirmed that microbiota‐derived metabolites contributed to XSBO‐mediated cognitive improvement and neuroprotection. Mechanistically, XSBO inhibited lipopolysaccharide‐induced neuroinflammation by suppressing TLR4/MyD88/MAPK signaling activation. XSBO alleviates AD‐related cognitive impairment and neuroinflammation by modulating the gut microbiota–SCFA axis and inhibiting TLR4/MyD88/MAPK‐mediated inflammatory responses. These findings suggest that XSBO may serve as a promising dietary intervention for neurodegenerative disease management.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Institute of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
- School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Jiyuan Neurohealth Industry Research Institute of Guangdong Pharmaceutical University, Jiyuan, Henan, China.
Funding
- National Natural Science Foundation of China
- National Key R&D Program of China
- Joint Funds of National Natural Science Foundation of China
- National Key Research and Development Program of China
Cite
APA
Du, L., Yan, S., Ren, X., Hassan, S. S. U., Sun, Y., Gan, Y., Xiao, X., Li, S., & Jin, H. (2026). Breaking Alzheimer's Disease Barrier: The Role of Xanthoceras sorbifolia Bunge Oil in Gut‐Brain Axis and TLR4 /Myd88/ MAPK Pathway Inhibition. Phytotherapy Research, 40(11), 6216-6232. https://doi.org/10.1002/ptr.70432
Vancouver
Du L, Yan S, Ren X, Hassan SSU, Sun Y, Gan Y, et al. Breaking Alzheimer's Disease Barrier: The Role of Xanthoceras sorbifolia Bunge Oil in Gut‐Brain Axis and TLR4 /Myd88/ MAPK Pathway Inhibition. Phytotherapy Research. 2026;40(11):6216-6232. doi:10.1002/ptr.70432
BibTeX
@article{Du2026,
author = {Du, Lijing and Yan, Shikai and Ren, Xiaopeng and Hassan, Syed Shams Ul and Sun, Yuanfang and Gan, Yu and Xiao, Xue and Li, Shasha and Jin, Huizi},
title = {Breaking Alzheimer's Disease Barrier: The Role of Xanthoceras sorbifolia Bunge Oil in Gut‐Brain Axis and TLR4 /Myd88/ MAPK Pathway Inhibition},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {11},
pages = {6216--6232},
doi = {10.1002/ptr.70432}
}
EUVIMED